Product
AGAR T
1 clinical trial
6 indications
Indication
Liver CancerIndication
RhabdomyosarcomaIndication
Malignant Rhabdoid TumorIndication
LiposarcomaIndication
Wilms tumorIndication
yolk sac tumorClinical trial
Interleukin-15 Armored Glypican-3-specific Chimeric Antigen Receptor Expressing Autologous T Cells as Immunotherapy for Children With Solid TumorsStatus: Recruiting, Estimated PCD: 2025-02-01